RELINIFY
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

RELINIFY Trademark

Serial Number: 97589986

RELINIFY is a trademark filed by Protagonist Therapeutics, Inc. on September 13, 2022. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

Protagonist Therapeutics, Inc. (9 trademarks)

Suite 140
Newark, CA 94560

Entity Type: 03

TAKEDA PHARMACEUTICALS U.S.A., INC. (73 trademarks)

500 Kendall Street
Cambridge, MA 02142

Entity Type: 03

Trademark Details

Filing Date

September 13, 2022

Registration Date

Not Registered

Published for Opposition

August 29, 2023

Goods & Services

Pharmaceuticals for use in the treatment of cancer and blood diseases and disorders

Medical information services in the fields of pharmaceuticals, oncology, and blood diseases and disorders

Medical research and medical research information services in the fields of pharmaceuticals, oncology, and blood diseases and disorders

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 28, 2026 EXRA
SOU EXTENSION 5 GRANTED
Jan 28, 2026 EX5G
SOU EXTENSION 5 FILED
Jan 28, 2026 EXT5
SOU TEAS EXTENSION RECEIVED
Jan 27, 2026 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 15, 2025 EXRA
SOU EXTENSION 4 GRANTED
Sep 3, 2025 EX4G
SOU EXTENSION 4 FILED
Sep 3, 2025 EXT4
SOU TEAS EXTENSION RECEIVED
Sep 3, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 10, 2025 EXRA
SOU EXTENSION 3 GRANTED
Feb 7, 2025 EX3G
SOU EXTENSION 3 FILED
Feb 7, 2025 EXT3
SOU TEAS EXTENSION RECEIVED
Feb 7, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 22, 2024 EXRA
SOU EXTENSION 2 GRANTED
Nov 22, 2024 EX2G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Nov 21, 2024 AITU
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Oct 23, 2024 ASGN
SOU EXTENSION 2 FILED
Oct 18, 2024 EXT2
SOU TEAS EXTENSION RECEIVED
Oct 18, 2024 EEXT
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 17, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Oct 17, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 17, 2024 REAP
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 13, 2024 EXRA
SOU EXTENSION 1 GRANTED
Mar 12, 2024 EX1G
SOU EXTENSION 1 FILED
Mar 12, 2024 EXT1
SOU TEAS EXTENSION RECEIVED
Mar 12, 2024 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Oct 24, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 29, 2023 NPUB
PUBLISHED FOR OPPOSITION
Aug 29, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 9, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 20, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 18, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 17, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 17, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 26, 2023 GNRN
NON-FINAL ACTION E-MAILED
Jun 26, 2023 GNRT
NON-FINAL ACTION WRITTEN
Jun 26, 2023 CNRT
ASSIGNED TO EXAMINER
Jun 25, 2023 DOCK
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 5, 2023 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jan 5, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 5, 2023 REAP
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 28, 2022 NWOS
NEW APPLICATION ENTERED
Sep 16, 2022 NWAP